Sykehuset i Vestfold HF
Quick facts
Marketed products
- Pivamdinocillin · Infectious Disease
Pivmecillinam works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Sykehuset i Vestfold HF
What are Sykehuset i Vestfold HF's marketed drugs?
Top marketed products include Pivamdinocillin.
Related
- Pivamdinocillin · Infectious Disease
- Sector hub: All tracked pharma companies